Influenza viruses cause substantial morbidity and mortality in pregnant women and neonates worldwide annually, with higher incidence during pandemics.1,2 To reduce disease incidence in these vulnerable populations, the World Health Organization recommended in 2012 that countries prioritize pregnant women for influenza vaccination.2 Over 2 decades, compelling evidence has accumulated about the complex interplay among risks of influenza virus infection to the mother, the fetus, and the offspring, vs the benefits and safety of vaccination.1-4
Azziz-Baumgartner E, Grohskopf L, Patel M. Realizing the Potential of Maternal Influenza Vaccination. JAMA. 2021;325(22):2257–2259. doi:10.1001/jama.2021.7776
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: